N/A
Completed N=40
Effect of VR on Pain and Patient Satisfaction in Adults Receiving GNRFA
Postoperative Pain · Patient Satisfaction
Source: ClinicalTrials.gov NCT05468398 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Peak Pain Intensity During Genicular RFA Procedure — 75.8; 70.6 units on a scale
Summary
The study team aims to investigate whether implementing virtual reality therapy (VRT) during Genicular nerve radiofrequency ablation (GNRFA) procedure will provide better alleviation of procedural pain and augmented satisfaction for patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Peak Pain Intensity During Genicular RFA Procedure |
75.8; 70.6 | — |
| PRIMARY Patient Satisfaction With VR Device |
93.4 | — |
| SECONDARY Patient Anxiety During Genicular RFA Procedure |
67.5; 55 | — |
| SECONDARY Provider Satisfaction During Procedure |
60.8; 91.7 | — |
| SECONDARY Use of Additional Local Anesthetic During Genicular RFA Procedure |
5; 3; 15; 17 | — |
| SECONDARY Provider Perception of Patient's Pain During Genicular RFA Procedure |
70.8; 36.9 | — |
| SECONDARY Prior Knee Radiofrequency Ablation |
0; 0; 20; 20 | — |
| SECONDARY Prior Experience With Virtual Reality (VR) |
5; 5; 15; 15 | — |
| SECONDARY Side Effects Associated With Virtual Reality During Genicular RFA Procedure |
0; 0; 20; 20 | — |
| SECONDARY Duration of Time Spent Thinking About Pain During Genicular RFA Procedure |
— | — |
Eligibility Criteria
Inclusion Criteria
- Patients aged 18 or older
- Patients Undergoing a genicular nerve radiofrequency ablation
- Patients who have previously received nerve blocks or radiofrequency ablation procedures may be included
Exclusion Criteria
- Requiring sedation during procedure
- Cognitive impairment or dementia
- History of recent stroke, epilepsy, psychosis, or claustrophobia
- Blindness or deafness
- Refusal to use the headset
- Isolation status for infection control
- Motion sickness or active nausea/vomit
- Pregnancy (Pregnancy testing point of care available for females of child bearing age)
Data sourced from ClinicalTrials.gov (NCT05468398). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.